Home About us Contact | |||
Secondary Tumours (secondary + tumour)
Selected AbstractsSecondary breast cancer: a 5-year population-based study with review of the literatureAPMIS, Issue 10 2009TOR AUDUN KLINGEN Secondary tumours in the breast are rare. Based on literature, an incidence of 0.4,2% is reported. In this population-based study, secondary breast tumours from a 5-year period (2001,2005), not including metastasis from contralateral breast carcinoma, were reviewed (Vestfold County, Norway). A total of 722 patients with breast malignancies were found in this population (89.3% from Vestfold County Hospital). Ten of these, approximately 1.4%, were metastatic tumours, representing four cutaneous melanomas, three pulmonary carcinomas and three malignant lymphomas. The tumours were often solitary, palpable and close to the skin. Radiologically, the lesions mostly resembled primary carcinomas by mammography and ultrasound, which differs from other studies. Comparison with a known primary tumour and use of immunohistochemical profiling is of crucial importance. Melanoma markers (Melan-A, HMB-45, S-100 protein), lung cancer markers (Cytokeratins, TTF1, Chromogranin, Synapthophysin) and lymphoid markers (CD3, CD20) usually help to confirm a secondary breast tumour diagnosis. This approach is especially indicated in diffusely growing tumours with lack of glandular structure and high-grade cytological features, and staining for ER and GCDFP15 may be helpful. Thus, the diagnosis of a breast metastasis may be suspected by careful mammography and ultrasound imaging, although some cases have atypical radiological features, and histological examination might be necessary to ensure a correct diagnosis and appropriate treatment. [source] Poorly differentiated tumours of the anal canal: a diagnostic strategy for the surgical pathologistHISTOPATHOLOGY, Issue 1 2007B Balachandra Poorly differentiated malignancies affecting the anal canal are uncommon but pose diagnostic difficulties because of the wide range of normal cell types that may occur within a limited anatomical region. The range of lesions that may present as poorly differentiated tumours includes squamous cell carcinoma, adenocarcinoma, small and large cell neuroendocrine carcinoma, neuroendocrine carcinoma expressing epithelial cytokeratins and other patterns of mixed differentiation, undifferentiated carcinoma, malignant melanoma, lymphoma and secondary tumours. This review discusses the differential diagnosis of these neoplasms with the aid of short illustrative case studies. [source] Differential diagnosis of T2 hyperintense spinal cord lesions: Part BJOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Issue 2 2009P Bou-Haidar Summary Hyperintense spinal cord signal on T2-weighted images is seen in a wide-ranging variety of spinal cord processes. Causes including simple MR artefacts, trauma, primary and secondary tumours, radiation myelitis and diastematomyelia were discussed in Part A. The topics discussed in Part B of this two part series include multiple sclerosis, subacute combined degeneration of the spinal cord, cord infarction, arteriovenous shunts, transverse myelitis, neurosarcoidosis, AIDS-associated vacuolar myelopathy, and syringohydromyelia. Characterization of the abnormal areas of T2 signal as well as their appearance on other MR imaging sequences, when combined with clinical context and laboratory investigations, will often allow a unique diagnosis, or at least aid in narrowing the differential diagnosis. A wide range of instructive cases is discussed here, with review of the published reports focusing on pertinent MR features to aid in diagnosis. [source] Biology of colorectal liver metastases: A reviewJOURNAL OF SURGICAL ONCOLOGY, Issue 1 2006Nigel C. Bird Abstract Metastatic growth is a selective, non-random process, which in the case of colorectal cancer, frequently occurs in the liver and is the major cause of cancer related death in these patients. This review summarises attempts to find biological and molecular markers of metastasis and their role in establishment of secondary tumours. Recent evidence suggests that liver metastases are phenotypically different to the primary from which they were derived and thus represent a separate disease entity. J. Surg. Oncol. 2006;94:68,80. © 2006 Wiley-Liss, Inc. [source] Primary and secondary tumours of the optic nerve, with emphasis on invasion of uveal malignant melanomaACTA OPHTHALMOLOGICA, Issue 3 2007Jens Lindegaard No abstract is available for this article. [source] |